U.S. Fifth Circuit Reverses Defense Verdict where District Court Had Not Conducted Daubert Hearing re Chiropractor Testimony Elicited by Defendants

In What's New in Product Liability Law?, What's New in the Courts by gravierhouseLeave a Comment

Patient who suffered severe injuries after being treated with infrared therapy device for diabetic condition of peripheral neuropathy brought products liability action against manufacturer and distributor. After denying patient’s pre-trial motion to exclude testimony of chiropractor, the jury found for the defendants.  The U.S. Fifth Circuit reversed and remanded for Daubert consideration: “Initially, we dispose of the defendants’ contention that …

Supreme Court of Delaware Holds that Registration to Do Business in State Does Not Confer Personal Jurisdiction

In What's New in Product Liability Law?, What's New in the Courts by gravierhouseLeave a Comment

The Delaware Supreme Court held that the U.S. Supreme Court’s decision in Daimler AG v. Bauman, 134 S.Ct. 746 (2014), effectively overruled the prior Delaware caselaw permitting Delaware courts to exercise jurisdiction over corporations that had registered to do business in the state. In this particular case, a large Georgia corporation that had properly registered to do business in the …

U.S. Magistrate Judge in the Connecticut Declines to Compel Production from Defendant’s Overseas Manufacturer

In What's New in E-Discovery and Spoliation?, What's New in Product Liability Law?, What's New in the Courts by gravierhouseLeave a Comment

In a suit against General Electric regarding alleged defects in GE branded microwaves, the plaintiffs sought to compel GE to produce discovery from Samsung Electrics Co., Ltd. (Samsung Korea), the manufacturer of the microwaves at issue.  Plaintiffs’ motion to compel was denied. “The relationship between GE and Samsung Korea does not evidence GE’s legal entitlement to the documents: they are completely different entities; GE is …

MDL Judge in Xeralto Denies Motion to Limit Ex Parte Communications with Treating Physicians

In What's New in Product Liability Law?, What's New in the Courts by gravierhouseLeave a Comment

In the Multi-District Litigation pending in the Eastern District of Louisiana regarding the drug, Xeralto, Judge Fallon recently issued an order addressing two separate motions brought by the defendants: (i) a motion to limit ex parte communications between plaintiffs’ counsel and the plaintiff’s prescribing and/or treating physicians, and (ii) a motion to permit the defendants to hire experts who may have …

New York Superior Court Denies Motion to Seal Documents in Product Liability Action in the Interest of Public Policy

In For Trial Lawyers, What's New in Product Liability Law?, What's New in the Courts by gravierhouseLeave a Comment

Two parents sued Graco after their child died due to an alleged defect in a Graco stroller. The parties negotiated a settlement that contained a confidentiality agreement, and the plaintiffs filed an unopposed motion to seal with the court. While acknowledging the propriety of confidentiality of court proceedings under limited circumstances, the court noted that the inquiry into whether to …

U.S. Ninth Circuit Upholds $2.7 Million in Sanctions Against Goodyear and Its Attorneys for Discovery Abuses Uncovered After Settlement and “History of Engaging in Serious Discovery Misconduct” in G159 Cases

In Legal Ethics & Professionalism, What's New in Product Liability Law?, What's New in the Courts by gravierhouseLeave a Comment

In June 2003, the plaintiffs were seriously injured when one of the Goodyear G159 tires on the front of their motor home failed, causing their vehicle to swerve off the road and overturn. They filed suit against Goodyear in 2005 in Arizona state court. The case was quickly removed to federal court. Goodyear was represented by Basile J. Musnuff, who …

Actos MDL Judge Approves a 25:1 Punitive Damage Ratio against the Manufacturers

In What's New in Product Liability Law?, What's New in the Courts by gravierhouseLeave a Comment

Judge Doherty, sitting in the Western District of Louisiana, and presiding over the Actos multi-district litigation, approved a ratio of 25:1 in punitive damages to compensatory damages, resulting in an award of punitive damages against Takeda in the amount of $27,656,250.00 and against Lilly in the amount of $9,218,750.00, where: – The Defendants knew or should have known that their product increased …

U.S. Fifth Circuit Refuses to Revive Claims Against Brand Manufacturer for Injuries from Generic Version of Drug (Reglan).

In What's New in Product Liability Law?, What's New in the Courts by gravierhouseLeave a Comment

Plaintiff argued that the US Supreme Court’s decision in PLIVA v. Mensing, 131 S.Ct. 2567 (2011) should render the brand manufacturer liable for the warning label and other properties utilized by generic manufacturers.  According to the plaintiff, Mensing undermined the logic of the U.S. Fourth Circuit’s decision in Foster v. American Home Products Corp., 29 F.3d 165 (4th Cir. 1994) (relied …

U.S. Supreme Court Holds State Law Claims Preempted by the Locomotive Inspection Act.

In What's New in Product Liability Law?, What's New in the Courts by gravierhouseLeave a Comment

Plaintiff was employed as a welder and machinist who worked in locomotive repair and maintenance facilities. In 2005, he was diagnosed with mesothelioma, and filed suit in Pennsylvania State Court against 59 defendants, including respondents RFPC and Viad, who distributed locomotive brakeshoes locomotive engine valves containing asbestos. The Locomotive Inspection Act (LIA) provides that: A railroad carrier may use or …

U.S. Fifth Circuit Sustains Claim for Breach of Implied Warranty Against Hip Manufacturer to the Extent that Defendant Did Not Comply with Requirements of FDA.

In What's New in Product Liability Law?, What's New in the Courts by gravierhouseLeave a Comment

Patient who underwent hip replacement surgery sued company that designed, manufactured, and marketed hip prosthesis that malfunctioned under number of theories including products liability, negligence, and breach of warranty, as well as the Texas Deceptive Trade Practices Act. “In summary, Bass pleaded: (1) he received a Shell implant; (2) the FDA had previously warned Stryker of bioburden in excess of …